These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
568 related items for PubMed ID: 25722447
1. The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study. Zhang G, Li J, Wang X, Ma Y, Yin X, Wang F, Zheng H, Duan X, Postel GC, Li XF. J Nucl Med; 2015 Apr; 56(4):607-12. PubMed ID: 25722447 [Abstract] [Full Text] [Related]
3. Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET. Cherk MH, Foo SS, Poon AM, Knight SR, Murone C, Papenfuss AT, Sachinidis JI, Saunder TH, O'Keefe GJ, Scott AM. J Nucl Med; 2006 Dec; 47(12):1921-6. PubMed ID: 17138734 [Abstract] [Full Text] [Related]
4. The Effect of Carbogen Breathing on 18F-FDG Uptake in Non-Small-Cell Lung Cancer. Lin Y, Bao YN, Huang CX, Zhang JH, Yu ZL, Tian Y, Wang XC, Cui YT. Biomed Res Int; 2019 Dec; 2019():2920169. PubMed ID: 31886195 [Abstract] [Full Text] [Related]
5. (18)F-fluoromisonidazole PET reveals spatial and temporal heterogeneity of hypoxia in mouse models of human non-small-cell lung cancer. Cui YL, Wang X, Li XF. Future Oncol; 2015 Dec; 11(20):2841-9. PubMed ID: 26361064 [Abstract] [Full Text] [Related]
6. PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients. Bollineni VR, Kerner GS, Pruim J, Steenbakkers RJ, Wiegman EM, Koole MJ, de Groot EH, Willemsen AT, Luurtsema G, Widder J, Groen HJ, Langendijk JA. J Nucl Med; 2013 Aug; 54(8):1175-80. PubMed ID: 23753185 [Abstract] [Full Text] [Related]
8. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y. Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [Abstract] [Full Text] [Related]
13. Synthesis and Bioevaluation of Novel [18F]FDG-Conjugated 2-Nitroimidazole Derivatives for Tumor Hypoxia Imaging. Yang X, Wang F, Zhu H, Yang Z, Chu T. Mol Pharm; 2019 May 06; 16(5):2118-2128. PubMed ID: 30964298 [Abstract] [Full Text] [Related]
15. Comparison of [18F]FDG uptake and distribution with hypoxia and proliferation in FaDu human squamous cell carcinoma (hSCC) xenografts after single dose irradiation. Bruechner K, Bergmann R, Santiago A, Mosch B, Yaromina A, Hessel F, Hofheinz F, van den Hoff J, Baumann M, Beuthien-Baumann B. Int J Radiat Biol; 2009 Sep 06; 85(9):772-80. PubMed ID: 19657862 [Abstract] [Full Text] [Related]
19. Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. Dearling JL, Flynn AA, Sutcliffe-Goulden J, Petrie IA, Boden R, Green AJ, Boxer GM, Begent RH, Pedley RB. J Nucl Med; 2004 Jan 06; 45(1):101-7. PubMed ID: 14734681 [Abstract] [Full Text] [Related]
20. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. Higashi K, Ueda Y, Arisaka Y, Sakuma T, Nambu Y, Oguchi M, Seki H, Taki S, Tonami H, Yamamoto I. J Nucl Med; 2002 Jan 06; 43(1):39-45. PubMed ID: 11801701 [Abstract] [Full Text] [Related] Page: [Next] [New Search]